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Abstract
Background: Most information on genomic variations and their associations with phenotypes are covered
exclusively in scientific publications rather than in structured databases. These texts commonly describe variations
using natural language; database identifiers are seldom mentioned. This complicates the retrieval of variations,
associated articles, as well as information extraction, e. g. the search for biological implications. To overcome these
challenges, procedures to map textual mentions of variations to database identifiers need to be developed.
Results: This article describes a workflow for normalization of variation mentions, i.e. the association of them to
unique database identifiers. Common pitfalls in the interpretation of single nucleotide polymorphism (SNP)
mentions are highlighted and discussed. The developed normalization procedure achieves a precision of 98.1 %
and a recall of 67.5% for unambiguous association of variation mentions with dbSNP identifiers on a text corpus
based on 296 MEDLINE abstracts containing 527 mentions of SNPs.
The annotated corpus is freely available at http://www.scai.fraunhofer.de/snp-normalization-corpus.html.
Conclusions: Comparable approaches usually focus on variations mentioned on the protein sequence and neglect
problems for other SNP mentions. The results presented here indicate that normalizing SNPs described on DNA
level is more difficult than the normalization of SNPs described on protein level. The challenges associated with
normalization are exemplified with ambiguities and errors, which occur in this corpus.
Introduction
Sequence variations are changes of the genetic material,
usually DNA, of an organism. They are important to
increase the variance of the genetic pool of species but
may also lead to severe hereditary diseases like Hunting-
ton disease, Cystic fibrosis or Hemophilia. Two terms
are commonly distinguished when referring to variations
on the DNA level: mutation and polymorphism. Poly-
morphism are alterations with a minor allele frequency
of ≥ 1 % in a particular population. Variations with a
lower frequency are usually called mutation. However,
the term mutation is also often used to imply a deleter-
ious effect of a sequence variation without any knowl-
edge about the underlying frequency distribution.
Throughout this publication we use the term variation
to describe arbitrary changes in a genomic sequence
while variation mention refers to the textual description
of a variation. Differences in a single nucleotide between
members of one species are referred to as single nucleo-
tide polymorphism (SNP). SNPs are a subclass of
sequence variations, encompassing single base
exchanges, single base deletions and single base inser-
tions. It is assumed that 90 % of all human sequence
variants are SNPs [1] and that they occur in average
about every 100 to 300 bases [2,3]. SNPs are, therefore,
the major source of human genetic heterogeneity. Dis-
eases like Sickle–cell anemia, b Thalassemia or Cystic
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associated with the metabolism of different drugs [7-9]
and are, therefore, relevant for research areas like phar-
macogenomics. SNPs without an observable impact on
the phenotype are still useful as genetic markers in gen-
ome wide association studies, because of their sheer
quantity and the stable inheritance over generations.
Information on SNPs is covered in curated databases.
Nevertheless, the wealth of information about the clini-
cal impact of SNPs is contained in free text in the form
of biomedical publications. At the moment, PubMed
provides access to more than 19 million citations con-
tained in MEDLINE. The described SNP mentions need
to be interpreted to be valuable, either by a human
curator alone or supported by a text mining system.
This interpretation often requires the normalization of
the SNP mention. By normalization we refer to the asso-
ciation of SNP mentions in text with their correspond-
ing database identifiers, for instance from a sequence
database such as dbSNP.
The interpretation of SNP mentions is challenging due
to ambiguous use of different nomenclatures, missing
information in a publication or sloppiness in the
description. Automated text mining methods are able to
extract SNP mentions from text, but only few associate
these with unique identifiers in SNP databases.
The main contribution of this paper is the description
and analysis of these challenges and to provide back-
ground knowledge to either build such a system or to
interpret SNP mentions in text. The paper is organized
as follows: A brief summary of different SNP data
sources is given in Section SNP Data Sources, followed
by a description of different problems of finding a data-
base identifier for a SNP mention in Section Normaliza-
tion Process. This section reviews the evolution of a
human mutation nomenclature, common problems in
named entity recognition, provenance and other pro-
blems. Subsequently previous approaches for automated
extraction of variation mentions are discussed. The gen-
eration of a corpus and the implementation of our nor-
malization algorithm is described in Section Methods
and the relevancy of error types is estimated on this cor-
pus in Section Results and Discussion.
SNP data sources
Detailed information about SNPs can be found in var-
ious databases like Online Mendelian Inheritance
(OMIM) [10], jSNP [11], or the Human Gene Muta-
tion Database [12]. OMIM focuses on the relationship
between phenotype and genotype and cites the corre-
sponding publications while jSNP is a repository of
Japanese SNP data and the Human Gene Mutation
Database constitutes a collection of data on germ-line
mutations.
All these databases have links to the dbSNP database
[13], which is the most comprehensive resource with 55
organisms and more than 63 million unique SNP
entries. Every single entry is accessible via a unique
database identifier called refSNP or “rs number”.T h e
content of dbSNP is interconnected with many other
resources, e. g. EntrezGene [14], GenBank [15], the Uni-
versal Protein Resource (UniProt) [16], HapMap [17],
Ensembl [18] or SNPedia [19].
All these different sources contain valuable informa-
tion like primer sequence, population frequency or
information on the corresponding gene, but only little
about the biomedical implication. This information is
mostly covered in publications, which are stored in data-
bases like MEDLINE. The National Center for Biotech-
nology Information (NCBI) provides references to 4487
articles for 24079 dbSNP entries. Due to high-through-
put techniques like SNP-arrays [20], mass spectrometry
[21,22], and new DNA sequencing methods [23,24], the
amount of SNP related data and publications is rapidly
increasing. The number of articles annotated with
MeSH term “polymorphism, single nucleotide” is
depicted in Figure 1.
In the following, we describe characteristics regarding
the process of finding database identifiers for free text
mentions of human SNPs. More precisely, this work
focuses on SNP substitutions in Homo sapiens with
about 18 million entries (as of dbSNP version 128).
Normalization process
Workflow
A general workflow for the automated extraction of SNP
mentions from literature is illustrated in Figure 2. The
figure shows required subtasks for the extraction and
subsequent normalization of SNP mentions. The indivi-
dual tasks are subsequently described and task specific
problems are highlighted. For the description of the
concrete implementation we refer to the Methods
section.
In contrast to a human who typically perceives the pro-
v i d e dd o c u m e n ti nt h ep u b l i s h e df o r mb e s t( e. g. hard
copy, pdf, html), an automated machinery needs a uni-
form text representation that necessitates a preprocessing
step (conversion of XML formats or extraction of plain
text from full text documents). The mentions of SNPs in
different nomenclatures or natural language need to be
detected as well as the gene names. While this task is
typically easily accomplished by a human, it is challen-
ging for an automated system due to the huge amount of
different complex formulations found in free text.
Based on the detected SNP mention and the gene/pro-
tein names (and their normalization to the databases
like EntrezGene or UniProt) and their association, the
normalization process is performed. This process is
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highly problematic for other formulations.
The aim of SNP normalization is to correctly associate
SNP mentions in text with unambiguous database iden-
tifiers. Thus, it is necessary to understand how these
entities are typically described. To normalize a SNP the
wild type, mutated allele,a n dlocation on the reference
sequence is required. Further the underlying gene or
protein needs to be identified. Whereas the terms wild
type and mutated allele describe biological concepts, the
r u l e st od e t e r m i n et h ep o s i t i o no fav a r i a t i o no nac e r -
tain gene have changed recently. The following subsec-
tion describes the most important changes in the
nomenclature for human mutations.
Human mutation nomenclatures
This section briefly summarizes some concepts of
human mutation nomenclature and its evolution rele-
vant for the normalization of SNP mentions. Prior to
the first recommendation of a common nomenclature
many different descriptions were arbitrarily used. For
some alleles nicknames like “hemoglobin Crete” [25],
“haemoglobin Guantanamo” [26], “Factor IX Angers”
[27], “Factor IX Bordeaux” [27], or “a1-antitrypsin Pitts-
burgh” [28] were commonly used. As articles became
harder to interpret by non domain experts, in 1993 the
emerging problem of many different nomenclatures lead
to first initiatives to define a nomenclature covering dif-
ferent types of genetic variations.
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Figure 1 Number of articles annotated with MeSH Term: “polymorphism, single nucleotide”.
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DNA level. Variants located on an exon may be propa-
gated to mRNA and may consequently lead to a change
of the encoded polypeptide chain. Therefore, a SNP can
be described on at least one of these three levels. How-
ever, SNPs are usually described on protein or DNA
level. To distinguish between these two concepts, we
use the terms protein sequence mutations (PSM) and
nucleotide sequence mutations (NSM) [29]. For
instance, the first sentence of the publication from
Wolff et al. [30] describes the same SNP as NSM
(894G–– >T) and PSM (Glu(298)–– >Asp and E298D):
“The Glu(298)–– >Asp (E298D; 894G–– >T) poly-
morphism of eNOS (endothelial nitric oxide synthase)
has been related with cardiovascular disease.”
All three SNP mentions can be further associated with
the unambiguous dbSNP identifier rs1799983. For sim-
plicity, the following sections are focusing on SNPs, but
can be applied to many other types of variations
analogously. However, the description of complex varia-
tions, like changes within duplications, can become
rather complicated.
First recommendation for mutation mentions from 1993
In the first publications on this topic the idea that posi-
tions of PSM should always be deduced from the pri-
mary translation product was introduced [31,32]. This
seems reasonable, but previously described PSMs were
often deduced from mature proteins or cleavage pro-
ducts [33-35]. The first amino acid of the primary trans-
lation product, in human usually a methionine, is
defined as position +1. Earlier publications often started
to count one position after the initiator methionine,
because it is frequently cleaved. For example, the sickle
cell causing allele located on hemoglobin–b (HBB) is
usually referred to as a replacement of a glutamatic acid
b yav a l i n ea tp o s i t i o n6 ,o rc o m m o n l ya b b r e v i a t e d
G l u 6 V a lo rE 6 V .H o w e v e r ,t h ec o r r e s p o n d i n gd b S N P
entry rs334 reveals that the polymorphism is located on
position 7. Additional examples of PSMs with a position
shift of 1 in the HBB locus can be found at the corre-
sponding OMIM entry in the category “Allelic Variants”.
Consequently several suggestions to describe NSM
have been made. In contrast to PSM, no intuitive start
position exists. The first approach suggested to use the
exact 5’ cap site as position +1. If the exact cap site is
unknown, the most upstream known cDNA base is used
as start point. When publishing these recommendations
in 1993 and 1996 respectively, only few complete cDNA
sequences were available and the human genome project
was in its infancy. Therefore, it has been concluded that
this system leads to an arbitrary numbering based on
early sequence data. Bases upstream of the cap site
should be consecutively numbered as –1, –2, –3 and so
on. Numbering downstream follows the cDNA
sequence, meaning that only exonic regions are conse-
cutively numbered. Bases within an intronic region are
described by two numbers. The first number is the base
o ft h ec l o s e s te x o na n dt h es e c o n di st h er e l a t i v ed i s -
tance to this base. This convention allows to describe
intronic variants, without even knowing the exact length
of the intronic region. The recommendation to describe
NSMs on gene MECP2 using this first nomenclature are
depicted in Figure 3. To trace the changes in mutation
nomenclature two persistent examples are introduced
and labeled in the corresponding figures. Using the
described recommendations the first SNP is referred to
as 2C®A and the intronic SNP is described as 252
+2T®C.
Change of start position counting for nucleotide sequence
mutations in 1996
Numbering based on genomic DNA is the most robust
form of systematic nomenclature [36,37]. In this case,
the DNA bases are consecutively numbered from a
Plain Text
Gene/Protein Name Wildtype
Mutated Allele
Location
Normalized Name Variation Mention
Named Entity
Recognition
Associated Variation Mention
Text (XML, PDF, HTML)
Preprocessing
Normalization Association
Association
Normalized Variation Mention
Normalization
Figure 2 Representative workflow for extracting SNP
information from unstructured text.
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recommendations in 1996 and 1998 the full genomic
sequence was not available for all genes. The positions
of SNPs for MECP2 using genomic DNA are depicted
in Figure 4. Using this recommendation the two SNPs
are described as 4943C®A and 10490T®C.
Antonarakis as well as Beutler et al. [36,37] sug-
gested to use cDNA if no reliable genomic DNA
sequence is available. Instead of the exact cap site,
both publications recommended to use the adenine of
the initiator ATG site as common start position. To
avoid confusion regarding the type of used reference
sequence, the variation mention is preceded by “g.” for
genomic or by “c.” for cDNA. The accession number
for the used primary sequence database should be
mentioned in the text. SNPs occurring in introns have
to start with the abbreviation IVS (intervening
sequence) followed by the number of the intron where
the variation occurs. The following number determines
t h ed i s t a n c et ot h ec l o s e s te x o n .T h ed e r i v a t i o no f
positions for NSM on MECP2 using the described
changes is depicted in Figure 5. Using this nomencla-
ture, our example SNPs are described as -225C®A
and IVS2+2T®C.
Explicit statement of variation level in 2000
The nomenclature updates [38,39] introduced new con-
cepts to cover more complex sequence variations and to
reduce ambiguities. Every variation has to begin with a
single letter indicating the type of reference sequence
(genomic DNA, cDNA, mitochondrial DNA, RNA, or
protein) of the described variation. For example, the
description r.67g>u specifies that mRNA is used as refer-
ence sequence for this SNP. The nomenclature allows no
variation in the textual description of variation mentions,
which allows to extract them easily e. g. by regular
expressions. Variations occurring in the 3’UTR are desig-
nated with a preceding asterisk (*) and the distance to
the last base of the stop codon. Applying this nomencla-
ture to our example variations results in c.–225C>A and
c.26+2T>C. A visualization of the new recommendations
applied on MECP2 is depicted in Figure 6.
Update for intronic variations in 2007
In the most recent publication [40] rules introduced in
[38,39] were recapitulated. The IVS concept for intronic
variations has been replaced by the previously intro-
duced idea, that intronic SNPs are described by two
numbers. The first number presents the location of the
closest exonic base and the second number describes
CCG...CTgt...agGC..CCATG...AGgta...cag...TCC...GACT...TTT
Exon1
A c
Intron1 Exon2 Intron2 Exon4
1
2 128
128+1 129
129-1
227
226 228 252
252+1 253-1
253-2
604
605
10241
10240
1687
1688 1686
Figure 3 Illustration of the first recommendation for a common mutation nomenclature. Example annotation for parts of gene MECP2
(GenBank entry: NG_007107.1) using the first suggestions for a mutation nomenclature. Exonic sequence is labeled green, intronic regions are
labeled brown and the surrounding untranslated regions are labeled in blue. In the first suggestions for a common nomenclature the most 5’
sequence of the first exon is the start position. Adjacent bases are subsequently numbered. Variations occurring in intronic regions obtain two
numbers. The first describes the location of the closest exon and the second is the distance to this exons. As shown in this picture, intronic
positions are usually described in relation to the closer exon. The underlined ATG marks the start codon, where the leading adenine has been
later proposed as common start position. Using these recommendations the two SNPs are described as 2C®A and 252+2T®C
CCG...CTgt...agGC..CCATG...AGgta...cag...TCC...GACT...TTT
Exon1
A c
Intron1 Exon2 Intron2 Exon4
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71230
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72312
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Figure 4 Illustration of the recommendations using the genomic sequence. The example annotations for parts of the gene MECP2
(NG_007107.1) are following the genomic DNA numbering concept. Numbering starts at the beginning of the used reference sequence.
Following bases are consecutively numbered. Using these recommendations the two SNPs are described as 4943C®A and 10490T®C
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start with the accession number of the used reference
sequence followed by a colon and the description of the
variation (e. g. NM_005957.3:c.123G>T). These variation
mentions can be easily extracted by using regular
expression. The explicit statement of the used reference
sequence facilitates the normalization to a unique iden-
tifier. Our running examples are now depicted as
NG_007107.1(MECP2):c.–225C>A and NG_007107.1
(MECP2):c.26+2T>C. In these two examples the gene is
mentioned in brackets, because the used reference
sequence NG_007107.1 covers two genes (MECP2 and
IRAK1). The direct mention of the gene of interest in
the expression is required to avoid ambiguity. For
instance, the description NG_007107.1:c.1A>T may refer
to a substitution on both genes. An increasing number
of journals, like Human Mutation, insists on using the
latest recommendations for a common human mutation
nomenclature. The increasing complexity of guidelines
makes the description of newly discovered mutations an
error prone and time intensive process. Tools like Muta-
lyzer [41] assist the creation and validation of a valid
description of sequence variations and may help to
reduce human errors. For example, Mutalyzer converts
genomic coordinates to transcript orientated positions
and allows to validate the correct description of a sub-
mitted variation mention. Another application useful for
the conversion of different SNP description is SNP-con-
verter [42]. More and more publications describe SNPs
also in terms of dbSNP accession numbers [43], which
is supported by the latest mutation nomenclature. For
example, the mention rs2306220:A>G is a valid SNP
description.
For NSMs an intuitive but important issue is that
human genes often have more than one transcript var-
iant and every transcript has its own unique exon/intron
boundaries and start codon. Usually a NSM can be
described with respect to all associated reference
sequences. However, the description of a mutation may
differ between two reference sequences due to the
unique properties of a reference sequence. Explicitly
mentioning the used reference sequence including a ver-
sion number avoids this problem and is, therefore,
recommended.
Recapitulation
The guidelines to describe variations have been recently
changed [36-40]. For example the previously introduced
NSMs can be reported in several ways, depending on
the year of publication. The different notation variants
are depicted in Figure 7. It is noteworthy that the use of
CCG...CTgt...agGC..CCATG...AGgta...cag...TCC...GACT...TTT
Exon1
A c
Intron1 Exon2 Intron2 Exon4
-226
-225 -99
IVS1+1 -98
IVS1-1
1
-1 22 6
IVS2+1 IVS2-1
IVS2-2
378
379
10015
10014
1461
1462 1460
Figure 5 Illustration of the “intervening sequence” concept in human mutation nomenclature. The example annotations for parts of the
gene MECP2 (NG_007107.1) are following the IVS concept. In this nomenclature variant the adenine of the start codon is used as start position.
Variations located in intronic regions start with the abbreviation “IVS” followed by the number of the intron where the variation is located. The
consecutive number determines the distance to the next intron/exon boundary. Using these recommendations the two SNPs are described as –
225C®A and IVS2+2T®C
CCG...CTgt...agGC..CCATG...AGgta...cag...TCC...GACT...TTT
Exon1
A c
Intron1 Exon2 Intron2 Exon4
-226
-225
-99
-99+1 -98
-98-1
1
-1 22 6
26+1 27-1
27-2
378
379
*8554
*8553
1461
*1 1460
Figure 6 Illustration of the latest recommendations for human mutation nomenclature. This most recent nomenclature discards the IVS
concept for intronic variations. Instead, the concept introduced earlier using two numbers is again recommended. Variations occurring in the
3’UTR are labeled with a preceding asterisk and numbering starts at the beginning of the UTR. Using these recommendations the two SNPs are
described as c.–225C>A and c.26+2T>C
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each mutation can be unambiguously described. For
example intronic variations can be described on cDNA
reference sequence with respect to the 5’ or 3’ exon.
However, a common and unambiguous nomenclature is
important to reduce errors. For example, due to incon-
sistencies in notations, the distinct mutation c.439
443delGAAGT has been individually reported by two
research groups as different mutation (425del5 and
472del5) [44]. Additionally, various human errors have
been reported. Amino acids sharing the same initial let-
ter (e. g. Alanine, Arginine, Asparagine, and Aspartic
acid or Threonine, Tryptophan and Tyrosine) are often
wrongly abbreviated when using one letter abbreviations
[38]. Also counting errors in the description of muta-
tions have been reported [44].
Even though the rules to calculate the position of a
PSM remained unchanged since the first publication,
two commonly used numbering variants have been
reported:
F i r s t ,P S M sm a yb ed e d u c e df r o mt h em a t u r ep r o t e i n
instead of the precursor polypeptide. This is the case for
the protein Lymphotoxin-alpha (LTA), where the pre-
cursor peptide contains a signaling sequence from posi-
tion 1 to 34. After transport of LTA to the final
destination, the signaling peptide is cleaved by a signal
peptidase. This is the reason why some authors refer to
position 35 as 1 and vice versa. This specific information
is covered in the feature table of the corresponding Uni-
ProtKB entry P01374. This property has been described
and used by Yip et al. [34] to successfully normalize
PSMs deduced from the mature protein sequences. The
authors found that relevant information is covered in
the features Signal, Transit, Peptide, Propeptide and,
Var_seq of the corresponding UniProt entry.
The second problem is that some publications start to
count one position after the leading amino acid. There-
fore, some dbSNP entries have an offset of +1 compared
to the textual description. This has been previously
exemplified for the sickle cell allele Glu7Val located on
Hemoglobin beta (HBB). Evidence for cleavage of the
first amino acid can be found in the feature Initiator
methionine of the respective UniProt entry P68871.
Identification and association of gene and variation
entities
Challenges in named entity recognition
For the normalization of SNP mentions to sequence
database identifiers, detection of SNP mention and the
associated gene or protein names is crucial. For auto-
mated recognition, several tools have been proposed,
both for gene and protein names [45-51] and variation
mentions [29,33,34,52,53]. For details, we refer to the
original publications. Recognizing biological terms is
often mislead by the lack of a commonly accepted
nomenclature. Therefore, the problem of word sense
disambiguation and abbreviation disambiguation has to
be handled. Typical examples of words representing a
PSM and another biological concept are exemplified in
Table 1. The frequent occurrences of some of these
terms in MEDLINE highlight the relevancy of an elabo-
rate disambiguation system. An example for homon-
ymous gene names has been exemplified by Weeber et
al. [54] for the abbreviation PSA. PSA is a valid gene
identifier for prostate specific antigen (GeneID 354),
puromycin-sensitive aminopeptidase (GeneID 9520),
protein S, alpha (GeneID 5627) and phosphoserine ami-
notransferase (GeneID 29968). Additionally, the abbre-
viation corresponds to other concepts like psoriasis
arthritis, poultry science administration, pig serum albu-
min or psoriatic arthritis. The performance of different
text mining systems for gene mention recognition and
for gene normalization to database entries has been cri-
tically assessed in BioCreAtIvE I [55] and II [56].
2C→A
252+2T→C
1993
1996 -225C→A
IVS2+2T→C
c.-225C>A
c.26+2T>C
2000
2007
NG_007107.1(MECP2):c.-225C>A
NG_007107.1(MECP2):c.26+2T>C
Figure 7 Proposed spellings for mutations over the last years.
Table 1 Examples of mentions which may refer to a
variation or a different concept
Abbreviation Alternative concept Frequency
C3H Zinc finger protein ZF 25,241
E2F Transcription Factor 11,796
H2S Hydrogen sulfide H2S 3,726
T47D Breast cancer cell line 2,902
L5178Y L5178Y mouse lymphoma cells 2,736
T1D Type 1 diabetes 2,731
T98G Human glioblastoma cell line 1,244
H295R Adrenocortical carcinoma cell line 637
P4501A Cytochrome P4501A 485
Frequency is the occurrence of abbreviations over all MEDLINE abstracts.
Query performed 2009/01/21.
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For the normalization of SNP mentions, the location,
wild type and mutated allele have to be known.
Approaches relying on machine learning methods com-
monly identify wildtype, mutated allele and location
separately [43,57]. These approaches require subsequent
association with extracted sub-entities (alleles and loca-
t i o n )t ob u i l dac o m p l e t eS NP tuple. A descriptive
example is given in Figure 8, where two different NSMs
are identified. SNP tuples could be created by associat-
ing each location with the two closest alleles. In our
example this would create the triples (–19,C,G) and
(G,261,C), where the second triple would be wrong. To
circumvent this problem it may be useful to regard if
the preceding or succeeding word is a delimiting charac-
ter like a comma, bracket, or dot.
However, the creation of these tuples introduces a
new error source, but the use of machine learning
approaches to identify variation mentions in text has a
substantial advantage: Approaches relying on regular
expressions commonly extract only diallelic variations
like L69K or 32C–– > T .H o w e v e r ,f o rh u m a nt r i a l l e l i c
SNPs (rs3091244), tetraallelic SNPs (rs293806), or even
pentaallelic SNPs (rs1049092) have been observed. SNPs
like 82C–– >T/G are currently only extracted by
machine learning tools. Some authors describe only the
observed allele of a variation like “52L” or the genotype
like “–403 AT” or “–403 AA”. Even though these exam-
ples are not mutations, it is feasible to detect and nor-
malize such mentions. Approaches detecting alleles and
location separately provide more flexibility but the sub-
sequent association introduces an additional error
source.
Extraction of dbSNP identifiers
One kind of SNP mention found in biomedical text is
the direct citation of a dbSNP identifier. In such cases,
t h eS N Pc a nb eu n a m b i g u o u s ly identified and mapped
to dbSNP. In a previous experiment [43], such mentions
have been extracted with the regular expression “[rR]
[sS][ ]*[1–9][0–9]*”. On a test set of 300 extracted men-
tions, a recall of 100 % and a comparatively small preci-
sion of 74 % has been achieved. Similar to other named
entity recognition tasks, some extracted mentions
describe a different concept. A list of observed false
positives can be found in Table 2. The regular expres-
sion has been improved by accepting capital rs mentions
only, when keywords like “mutation” or “SNP” matched
and exclusion words like “strain” did not occur in the
abstract. The precision has been further improved using
a blacklist with recent false positives like rs61443. The
resulting tagger reached in a sub-sampling of 300 men-
tions a precision of 97 % at an approximate recall of 98
%. In the same publication it has been shown, that
direct mention of rs numbers in MEDLINE abstracts
increases steadily since 2002.
Gene-SNP association
Prior to a normalization each detected SNP mention has
to be correctly associated with the corresponding gene.
This is necessary because the location of a SNP is
described in relation to the corresponding gene. This is
ad i f f i c u l tt a s ke v e nw h e no n l yo n es i n g l eg e n eo rp r o -
tein is described in the text, because it is not guaranteed
that this gene or protein is mentioned together with the
SNP mentions in the text.
Several methods for the association of gene or protein
with the corresponding SNP have been proposed. Some
consider sentence boundaries [29], while other
approaches associate a SNP with all extracted genes and
try to validate the results using the dbSNP database
[43,53]. Another approach introduced the “graph bigram
association algorithm” for the purpose of building the
required protein-variation pairs [58]. The algorithm
removes all stop words from a text, builds a list of
bigrams and calculates the likelihood that two words
occur adjacent to each other using the t-statistic.
Regarding only articles with more than one possible
protein association the precision of the relation extrac-
tion using graph bigram is 84 % whereas the precision
of the word distance measure is 73 %.
Provenance
Genomic information rapidly changes over time. This
also includes the sequence of the genome and its
annotation. In 2004 the sequence of the human gen-
ome covered already 99 % of the euchromatin
sequence with an error rate of 0.01 ‰ [59]. However,
this sequence consisted of 308 gaps on euchromatic
material in regions which are hard to sequence.
··· in TIMP-1 (-19C-->G, 261C-->T) ···
Figure 8 Exemplified depiction of a paragraph annotated by a machine learning tool. Prior to normalization all sub-entities (alleles and
location) have to be combined into tuples of entities. In this example the location 261 can be wrongly associated with the two closest states G
and C. This can be circumvented by punishment of punctuation marks between two entities, like the comma in this case.
Thomas et al. BMC Bioinformatics 2011, 12(Suppl 4):S4
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genome underwent some updates since 2004. Without
additional information, the human genome is just a
long concatenation of characters using a comparatively
small alphabet (A,T,G,C). Annotation information of
the genomic sequence is needed to put meaning to
this heap of data. Genes are often annotated using evi-
dence like protein or cDNA sequences. Due to addi-
tional evidence or a change in the genome assembly
the structural annotation of genes may alter. The
change of annotated transcripts in the ENSEMBL data-
base between version V46 and V47 has been investi-
gated by the authors. Between these two versions the
algorithm for transcript and UTR placement has been
changed and therefore many changes can be expected.
Approximately 33 % (12,435/38,238) of all shared tran-
scripts had a different location for the start codon.
NSMs located on one of these transcripts would obtain
new position numbers.
Problems of not being able to normalize a SNP men-
tion because of database changes are hard to solve.
Changes in the reference sequence as well as merging or
renaming of identifiers are often not well documented.
To circumvent these problems, the latest human muta-
tion nomenclature advises authors to mention the acces-
sion number of the used reference sequence in front of
the variation description. Adherence of this rule simpli-
fies the normalization substantially, because the respec-
tive reference sequence is known.
It has been previously mentioned by Antonarakis et
al. [37], that the accession number of the used refer-
ence sequence should be additionally included in the
publication. However, in some publications the acces-
sion number is not mentioned in the abstract. There-
fore, it may be beneficial to incorporate the most
appropriate sequence based on the publication date of
an article. It is also crucial to use a SNP database
which is derived from the same genome build as the
used sequence database. Otherwise the position of a
SNP can be miscalculated. Only the most recent ver-
sion of dbSNP is available for download. However,
the mapping information to the previous build is
available.
Allele information in dbSNP
A SNP is always observable on both strands because of
the structure of DNA. Therefore, the alleles can be
described on any strand side. For example, the replace-
ment of an adenine by a cytosine on one strand leads to
ar e p l a c e m e n to fat h y m i n eb yag u a n i n eo nt h ea n t i -
parallel strand. To avoid confusion in the textual
description of variations, alleles are always described on
t h es a m es t r a n da st h er e f e r e n c es e q u e n c ea n dc D N A
sequences are usually on the same strand as the asso-
ciated gene.
In contrast, alleles in dbSNP may be arbitrarily located
on any strand side. This is based on the build process of
dbSNP. Submitted sequences obtain a unique and stable
submission sequence (ss) number. The submitted
sequence is aligned to the genome in question. Submis-
sion sequences describing the same SNP are merged
i n t oo n es i n g l er se n t r y .An e wr se n t r yi sg e n e r a t e d ,i f
no ss previously covered this specific sequence variation.
Regardless of the number of ss entries, every rs cluster
has exactly one reference sequence. The reference
sequence is always the longest submission sequence of
each cluster and may be arbitrarily located on the sense
or antisense strand. Therefore, the alleles are, depending
o nt h ea l i g n m e n to ft h es e q u e n c et ot h eg e n o m e ,
located on either strand. Due to this property, some
alleles of dbSNP are on the opposite strand than the
cDNA sequence. Information about the placement of a
SNP on the current contig can be found online in the
database table SNPContigLoc. Additionally information
about the placement of a contig on the chromosome is
contained in table ContigInfo.
Ambiguity between PSM and NSM
The shared alphabet between protein and nucleotide
sequences introduces another problem of ambiguity. For
example, the SNP A123T could describe a NSM or a
PSM. Several rules to disambiguate PSM and NSM are
described in [35]. An approach for this disambiguation
based on machine learning techniques is described in
[60].
Miscellaneous pitfalls
Additionally to the aforementioned problems, pitfalls
that are obvious but not neglectable are reported: 1.)
Some SNPs may not be contained in the SNP database
of interest. This may have several reasons like a missing
submission or a rather low minor allele frequency. 2.)
SNPs reported in non coding regions are difficult to
normalize as the current human mutation nomenclature
covers these only in terms of genomic descriptions.
Nevertheless, publications often describe these SNPs in
relation to the closest gene, which is not covered in
dbSNP. 3.) Not all needed information might be
Table 2 Examples for potentially wrong extracted dbSNP
identifiers using the naive regular expression [rR][sS][ ]*
[1–9][0–9]* interfering with different concepts [43]
rs number Alternative concept
rs1 Cell Line
rs6000 Computer Name
rs485 Computer Interface
rs1000 Indian Rupees
rs61433 Immune Suppressor
Thomas et al. BMC Bioinformatics 2011, 12(Suppl 4):S4
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associated gene might be only mentioned in the full text
article. 4.) Typos can basically appear in all types of
descriptions (alleles, locations,…)a n dm a ym a k et h e
normalization infeasible.
Previous approaches for SNP extraction
Manual extraction and normalization of SNP mentions
is time consuming but feasible for specific domain
topics. For example, the AlzGene database [61] contains
manually harvested information about SNPs from full
text publications associated with Alzheimer’s disease.
Collecting such information on large scale requires
automated methods due to the large amounts of pub-
lished literature. Several text mining approaches for dif-
ferent purposes have been developed in the Life Science
domain [62,63]. A typical problem for proper identifica-
tion of biological entities in text is the lack of a com-
mon and widely established nomenclature. In context
with the human variation nomenclature, many different
ideas have been discussed [31,32,36-39,64]. In compari-
son to other NER tasks, only a few publications concen-
trated on the identification of SNPs and other types of
small sequence variations in full text publications.
Horn et al. 2004
MuteXt [33] is an early method for the extraction of
single point polymorphisms. MuteXt uses regular
expressions to extract protein names and variation men-
tions. The system performance has been estimated for
the protein families “nuclear hormone receptors” (NR)
and “G-protein coupled receptors” (GPCR) and achieves
a precision of 87.9 % and 85.8 % and a recall of 49.3 %
and 64.5 % for GPCR and NR respectively.
Rebholz-Schuhmann et al. 2004
The tool MEMA [29] also uses regular expressions to
extract variation mentions and gene names. In contrast
to MuteXt, the system extracts variations on both
nucleotide and amino acid level using the HUGO
nomenclature [65] to automatically compile a dictionary
to extract gene names. On a validation set consisting of
100 randomly selected MEDLINE abstracts containing
either the key word “mutation” or “polymorphism” the
system achieves a precision of 75% and a recall of 98%.
Caporaso et al. 2007
An additional tool, solely concentrating on the extrac-
tion of non-synonymous variation mentions, is the freely
available application MutationFinder [52]. Nonsynon-
ymous mutations are a special type of SNP, because
they alter the encoded polypeptide chain and are there-
fore often described on amino acid level. The authors
created a set of 759 patterns, to cover the most recent
descriptions of variation mentions in text. On a pub-
lished validation set consisting of 508 abstracts with 910
variations the system achieves a precision of 98 % and a
recall of 81 %.
Yip et al. 2007
An alternative approach described by Yip et al. [34]
focuses on the enrichment of sequence variations in the
modSNP database [66]. Similarly to the previous
approaches, non-synonymous mentions are extracted
using regular expressions. Extracted variations are asso-
ciated with the respective protein, allowing for validation
of the extracted wild type amino acid with the amino
acid contained in the corresponding UniProt entry. The
authors describe rules to handle systematic errors based
on liberties in numbering of protein variation mentions.
This information includes evidence for post-translational
cleavage or alternative splicing, which may result in dif-
ferent sequence length and therefore in different
sequence numbering. The authors report that using the
annotation information covered in UniProt allows to
validate about 20 % more variation mentions. The sys-
tem achieves a precision of 89 % and recall of 84 % on
the validation corpus provided by MutationFinder.
Furlong et al. 2008
A different approach is OSIRIS V1.2 [53], which identifies
and normalizes any type of SNP (coding or non coding) to
dbSNP identifiers. After selecting the genes mentioned in
the abstract, the system retrieves all SNPs located on these
genes and their corresponding terminology according to a
SNP thesaurus. The terms are used for a pattern based
search in the text and if found, the variation mentions are
normalized to their corresponding database identifiers.
The system achieves a precision of 99 % with a recall of 82
% on a validation set of 105 articles.
McDonald et al. 2004 and Klinger et al. 2007
The usability of conditional random fields [67] to
extract variation mentions, has been demonstrated by
two approaches [43,57]. The latter approach also
extracts variation mentions described in the latest
human mutation nomenclature and direct mentions of
dbSNP identifier by regular expressions. For the extrac-
tion of protein and gene names, the rule and dictionary
based approach ProMiner [49] is used. A normalization
module maps identified variations to an unambiguous
dbSNP identifier based on the extracted entities. On a
corpus of 105 abstracts the normalization achieves a
precision of 78 % and recall of 67 %.
Rhee et al. 2008
While regular expression-based recognition of dbSNP
identifiers is a component of the previously mentioned
Thomas et al. BMC Bioinformatics 2011, 12(Suppl 4):S4
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the extraction of such mentions from MEDLINE articles
and OMIM. For this purpose, medRefSNP retrieves a
list of relevant articles and extracts all dbSNP identifiers.
The same is performed for all OMIM entries containing
“Allelic Variants”. Further information about extracted
SNPs is retrieved from dbSNP. Data on linkage disequi-
librium is downloaded from HapMap and cytoband
location from the UCSC genome browser [69]. SNPs
located on genes are mapped to their specific Entrez
Gene identifier. If available, pathway data for the gene is
retrieved from KEGG [70]. One disadvantage of the
described approach is that only direct rs mentions are
found in articles. Variations described only in terms of
natural language cannot be found.
Krallinger et al. 2008
An approach to extract human kinase mutations is pre-
sented by Krallinger et al. [35]. Mutation mentions are
extracted using MutationFinder and are classified into
the categories natural- or induced-variant using a sup-
port vector machine classifier. The authors describe sev-
eral simple but elegant rules to categorize ambiguous
mutation mentions into PSM or NSM. For instance,
99.25 % of all PSM annotated in UniProt have a position
number below 4000. Subsequently PSM are validated by
using sequence information of the associated protein.
Systematic errors in protein sequence numbering are
also handled by different strategies.
Recapitulation
All discussed approaches are able to identify variation
mentions in scientific texts. Although a framework for
the systematic analysis of mutation extraction systems
exists [71], the results of the described systems are, due
to the different foci, barely comparable. Some systems
like MuteXt, its successor Mutation GraB [58], the
approach published by Yip et al., Krallinger et al. and
Laurila et al. [72] validate extracted PSMs by comparing
the wild type amino acid with the amino acid stored in
the corresponding UniProt entry. These articles describe
observed problems concerning different residue num-
bering between the article and the protein sequence in
UniProt. However, association of PSMs with protein
identifiers is ambiguous, as different PSM may be asso-
ciated with the same protein. Furthermore, such
approaches neglect the normalization of NSM mentions,
which provide a much higher ambiguity than PSM and
are, therefore, more difficult to normalize.
Only OSIRIS and our approach associate extracted
variations with unique SNP identifiers. Prior to the nor-
malization of variations mentions with dbSNP, these
approaches associate variation mentions with the corre-
sponding gene or protein identifier. Therefore, these
two approaches not only provide a normalization of var-
iation mentions to dbSNP but also an association of var-
iation mention to the corresponding gene/protein.
Methods
Corpus generation
To find and describe typical real world problems, a cor-
pus consisting of SNP mentions associated with their
dbSNP accession number mentioned in the text has
been generated. Only few articles describe a variation in
terms of natural language and the corresponding rs
number. An initial list of 2,232 relevant articles has
been received from dbSNP help desk. These abstracts
were annotated by dbSNP and are known to mention at
least one dbSNP identifier. The 2,232 abstracts were
then automatically screened for SNP mentions using a
modified version of MutationFinder.
Modifications encompass five regular expressions
matching different NSM variants of the notations intro-
duced in Section Human Mutation Nomenclatures.
These modifications allow the detection of NSM men-
tions and are available in the supplementary material.
The strict amino-acid alphabet of MutationFinder has
been expanded to match ambiguous symbols like Xle,
which can be used to describe the two amino acids leu-
cine or isoleucine. Also different variations of termina-
tion symbols like term, amber or opal have been added
to detect nonsense mutations. Additionally, regular
expressions matching variation mentions using the latest
recommendations for a human mutation nomenclature
have been generated. The mutation mentions described
on the homepage of the human genome variation
society have been used for developing these regular
expressions.
All regular expressions have been applied to the initial
corpus of 2,232 articles. Extracted SNP mentions are
then manually checked and associated with the corre-
sponding dbSNP entry. SNPs missed by any of the regu-
lar expressions are also added into the corpus, if they
could be associated with a dbSNP identifier. Identical
descriptions were extracted only once per abstract. This
procedure resulted in 527 variation/rs number pairs.
From the 385 distinct rs numbers, 21 were found to use
outdated dbSNP identifiers. These were replaced by the
currently valid identifiers of dbSNP build 128.
The main properties of our corpus are as follows:
￿ The 527 SNP mentions can be separated into 283
PSM and 244 NSM.
￿ 48 SNP mentions refer explicitly to the type of used
reference sequence
￿ 19 SNP mentions use the IVS concept to describe
intronic variations
￿ 17 PSM are ambiguous as they could be potentially
interpreted as NSM
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For each rs number we extract information about the
associated gene, the position on the chromosome,
known alleles, and the orientation of the SNP in relation
to the associated gene. This information is extracted
from a local copy of dbSNP. If the SNP is located in the
coding region, the respective amino acid residues are
also extracted from dbSNP. To allow for compensation
of systematic differences in numbering, we follow the
approach described by Yip et al. and parse information
about post translational modifications from UniProtKB.
Gene centric information, like exon/intron boundaries
or the location of the start codon is extracted from
Entrez Gene and ENSEMBL databases. Although both
databases use the same genomic reference sequence, the
boundaries for some transcripts (and their number) dif-
fer. Therefore, information about transcripts has been
included from both databases. Gene name recognition
and normalization to Entrez Gene and UniProt is per-
formed using ProMiner. For evaluation we assume a
perfect named entity recognition of gene names, by
manually adding genes missed by ProMiner but required
for subsequent SNP-normalization. This information can
be gathered directly from the corpus, as dbSNP entries
are associated with their corresponding Entrez Gene
identifier. This allows a realistic assessment of the nor-
malization procedure as the normalization algorithm is
not influenced by the limited recall of a gene name
recognition procedure. Subsequently, the algorithm
retrieves for each SNP mention in the corpus a list of
dbSNP candidates. The list of candidates is collected by
retrieving all dbSNP entries associated with a gene con-
tained in the article. In other words the SNP mention is
associated with all genes mentioned in an article. The
method iterates over all dbSNP candidates and performs
a validation for the specific SNP mention.
The normalization algorithm for one SNP mention
and one dbSNP candidate is depicted in Figure 9. The
workflow disambiguates between PSM and NSM men-
tions. For ambiguous mentions like A123T the algo-
rithm pursues both normalization strategies:
1.) For normalization of PSM the method first
matches the extracted position against the dbSNP candi-
date. In case of a match the residues of the SNP men-
tion are compared against the dbSNP residues. If both
residues of the SNP mention are contained in the
dbSNP candidate, the algorithm normalizes the mention.
If the location of the SNP mention can not be validated,
the algorithm incorporates knowledge about post trans-
lational modifications from UniProtKB. If any post
translation modifications explains the difference in num-
bering the residues are validated. In case of a match the
SNP mention is associated with the candidate. Other-
wise the candidate is discarded.
2.) For NSM normalization the normalization proce-
dure is more sophisticated, as several counting variants
have been introduced. For each dbSNP entry we rebuild
all different counting variants as described in Section
Human Mutation Nomenclatures depending on the
information where the SNP is located (Exon, Intron,
UTR). These counting variants are calculated for each
reference sequence associated with the current candi-
date entry. The algorithm reverses alleles (e. g. A– >G
becomes T– > C ) ,i ft h ed b S N Pr e f e r e n c es e q u e n c ei s
located on the opposite strand than the reference
sequence. Again, the algorithm attempts to validate first
the position of the SNP mention with the dbSNP candi-
date. If the location of the SNP mention complies with
any of the counting variants the corresponding alleles
are also compared.
The algorithm does not distinguish between wildtype
and mutated allele/residue as this information is usually
based on the frequency in the observed population sam-
ple and does not necessarily resemble the recommenda-
tions for a human mutation nomenclature. Therefore,
the normalization procedure checks if both alleles/resi-
due are at the correct location, but allows changes in
the directionality (e. g. A– >G becomes G– >A).
Results and discussion
The general workflow described in Section Normaliza-
tion Process was implemented as mentioned in Section
Implementation details. The implementation correctly
found 356 out of 527 variation/dbSNP pairs. The recall
is 67.5% with a precision of 98.1 % (7 false positives in
total). These 356 true positive SNPs can be further
divided into 268 PSM and 88 NSM. Therefore, the recall
is 94.7 % and 36.0 % for PSM and NSM respectively.
Based on a manual inspection of each variation and the
challenges described in the previous sections, typical
problems and pitfalls are highlighted in the following.
Inspection of normalization issues
Protein sequence mutations
As previously described, two different counting variants
f o rP S Ma r ek n o w n .F i r s t ,t h r e eP S M sw i t ho n ed i g i t
lower than in the dbSNP entry have been found in the
corpus. The reason for the different numbering is that
the initiator amino acid is cleaved from the primary
translation product. This leads to the observed differ-
ence of 1 between the textual description and the
dbSNP entry. The corresponding authors were con-
tacted and affirmed the deprecated property of the sta-
ted description. The authors used this description,
because it is a long established term in the community.
For all PSMs this information is covered in the UniProt
feature initiator methionine. More information about
these specific mutations is described in Table 3.
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“sequence annotation” feature information from Uni-
ProtKB. A complete list of recovered SNPs is depicted
in Table 4. It shows which PSM could be recovered by
using which UniProtKB entry and feature. It is note-
worthy that not all PSMs could be recovered using Uni-
Prot as additional information source. For example, Ha
et al. [73] describe three different non synonymous
SNPs on gene SDC3. For all three SNPs a constant dif-
ference of 52 amino acids in comparison to the
described dbSNP entry can be observed. However, no
feature of the corresponding UniProtKB entry (O75056)
provides evidence for this constant offset. At present it
is unclear to us from which reference sequence these
positions have been derived. These PSMs could have
been normalized using the methods proposed in [35,72]
to handle systematic numbering errors for PSM.
Location of alleles on opposite strand side
As previously described, the dbSNP reference sequence
can be located on the opposite strand than in the men-
tioned NSM. This property is observed seven times in
the dataset. Therefore, the dbSNP entry describes the
alleles on the opposite strand than the variation mention
in the text. To successfully recover those variations one
has to reverse the alleles contained in the dbSNP
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Figure 9 Flow chart of the normalization procedure.
Table 3 Normalized SNPs which derive the location one
position after the leading amino acid
PMID dbSNP identifier Mention in text Mention in dbSNP
16489054 rs605059 Ser312Gly Ser313Gly
16525568 rs5985 Val34Leu Val35Leu
17241179 rs5985 Val34Leu Val35Leu
Table 4 Overview of all recovered polymorphisms using
UniProtKB as additional data source
PMID dbSNP
identifier
Variation UniProtKB
id
Used feature
16368448 rs5063 Val7Met P01160 Signal: 1-25
17196207 rs5882 I405V P11597 Signal: 1-17
17344938 rs1123617 Val227Ile Q15849 Var_Seq: 1-
523
17344938 rs3745009 Ala357Thr Q15849 Var_Seq: 1-
523
17517687 rs1041981 Thr26Asn P01374 Signal: 1-34
17634448 rs2230199 Arg80Gly P01024 Signal: 1-22
17944986 rs6136 Thr715Pro P16109 Signal: 1-41
18034366 rs5882 I405V P11597 Signal: 1-17
The fourth column refers to the used UniProtKB entry and the fifth column
shows which specific feature has been used to recover this variation.
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in Table 5.
Permutation of dbSNP identifiers
Additionally to these systematic errors, the numeric pat-
terns of five rs numbers are wrongly described in the
text. A detailed description can be found in Table 6. It
can be seen, that the rs numbers for three SNPs differ
only in one digit and for the remaining two entries two
digits have been transposed. It is noteworthy that the rs
number of the first variation “V660L” is described once
correctly and once wrongly in the abstract. It is there-
fore probable that the wrong description occurred due
to a transcription error. None of the remaining dbSNP
entries represent the described variation in the text.
Two variations (rs8192673 and rs861529) are located in
intronic regions and one (rs2308237) is located on geno-
mic background, where the described non synonymous
mutations cannot occur. For rs8192673 the error has
been discovered and an erratum has been published
[74]. Non-systematic errors like these may occur in dif-
ferent steps of the publication process. It is likely that
similar errors also happen for other numbers like the
location of an mutation or accession numbers. However,
such errors should be rare and we have not found such
errors in our corpus.
Independent from our corpus an error in the descrip-
tion of a SNP by Yoneyama et al. [75] has been
observed. The authors describe the substitution of an
alanine to proline at amino acid 459 in COL1A2. We
believe that the correct location is amino acid 549 and
the corresponding dbSNP identifier is rs42524. A first
indicator is that at position 459 an isoleucine is located
instead of the described alanine and no UniProtKB fea-
ture provides evidence for a systematic error. In the cor-
responding letter by Arnold et al. [76] the variation is
described as Ala549Pro (rs42524).
Duplicate dbSNP entries
Due to the building process of dbSNP more than one rs
entry for one SNP can be generated. This is the case
when the flanking region of the ss entries substantially
differs. In this case the genomic location for both
dbSNP entries is the same but the dbSNP entries are
not merged. This has been observed for two SNP men-
tions, which could be associated to both rs numbers.
T h ee n t r i e sa r es h o w ni nT a b l e7 .P l e a s en o t et h a tt h e
second mention has been already merged to rs6670 in
the latest dbSNP release.
dbSNP entries associated with no gene entry
During the analysis we observed that five dbSNP entries
are not associated with the gene mentioned in the text.
According to dbSNP the entries shown in Table 8, are
not associated with any gene. This is reasonable as all
mentions describe a variation located far upstream in
the promoter region of the gene mentioned in the text.
To normalize such mentions one would have to extract
the genomic coordinates of a gene and find dbSNP
entries approximate to this gene.
Ambiguity between PSM and NSM
The short form of 17 PSM is ambiguous in that it could
also be interpreted as a NSM. Some examples are pro-
vided in Table 9. All 17 mentions would have been cor-
rectly identified as PSM by the rules mentioned in [35].
It is noteworthy that this problem might be self-inflicted
as some tools, like MutationFinder, normalize amino
acids to one letter codes. For example the mention
Ala357Thr would be normalized to A357T and the
mention would have become ambiguous. Considering
that information would have allowed to classify 9 men-
tions as PSM. Therefore this simple rule could be added
to the ideas described by Krallinger et al. to distinguish
PSM and NSM.
From 244 NSM, 65 use a minus character, 30 mention
the used reference sequence (c. or g.), and 19 are
described by the IVS concept. Therefore 114 of 244
NSM could be previously classified as NSM. For the
remaining NSM the normalization algorithm performs a
NSM and PSM normalization.
Table 5 Normalized SNP mentions, where the alleles of
dbSNP (build 128) are located on the opposite strand
than the corresponding gene
PMID dbSNP identifier Variation Alleles in dbSNP
16144952 rs2077647 T30C A/G
17480010 rs1867561 –135C®G C/G
17495420 rs1572983 59G®A C/T
17630229 rs5569 G1287A C/T
17917281 rs5569 G1287A C/T
18203168 rs234706 C699T A/G
18280297 rs4614723 3823G®A C/T
Table 6 List of SNPs described by false dbSNP identifiers
in the publication
PMID Variation Specified dbSNP
identifier
Correct dbSNP
identifier
16614108 V660L rs1042638 rs1042838
17301261 1793G>A rs2274976 rs2274967
17390150 G482S rs8192673 rs8192678
17701750 T241M rs861529 rs861539
18268114 K178R rs2308237 rs2308327
The observed difference between correct and wrong identifier is highlighted
in bold and usually is one or two digits.
Table 7 SNPs with more than one valid dbSNP entry
PMID SNP rs number in text also valid dbSNP identifier
16652158 –77T>C rs11553656 rs3213245
17289909 A8618T rs45566835 rs6670
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The distinction between wild type and mutated residue/
allele is usually based on frequency in the specific popu-
lation sample. However, the human variation nomencla-
ture advises authors to use the nucleotide/residue of the
reference sequence as wild type. This sometimes leads
to a change in directionality between the alleles/residues
described in the mutation mention and the correspond-
ing database entry. This problem can be observed for 86
out of 244 (35.2%) NSM and 53 out of 283 (18.7%) PSM
in our corpus. Examples for flipped wildtype and
mutated alleles are provided in Table 10.
All problems observed in our corpus are summarized
in Table 11
Conclusions
Normalization and interpretation of SNP mentions is
highly challenging for human readers as well as auto-
mated machineries. In this paper, we discussed several
common pitfalls which have to be overcome for success-
ful normalization of variation mentions to dbSNP. Most
of them are generally valid and apply also for other SNP
databases.
In particular we depicted a number of observed real
world examples based on a corpus of 527 SNP/dbSNP
pairs. Using this corpus reveals non-systematic errors
like permutation of numbers, which are hard to find.
We demonstrate that our developed normalization algo-
rithm produces precise results for both PSM and NSM.
However, the recall for the normalization of PSM is
substantially better (94.7 %) than for NSM (36.0 %). We
believe that this might have several reasons: First, our
approach currently incorporates no provenance informa-
tion and uses only the latest gene annotations from
ENSEMBL and Entrez Gene. Second, the early papers
on mutation nomenclature pointed out, that the lack of
a complete reference sequence might lead to an almost
arbitrary position numbering and domain experts might
stick to these deprecated references. Third, manual con-
version of a SNP into any mutation nomenclature is,
without any computational assistance like Mutalyzer,
error prone. Finally, sequencing errors might lead to
small but substantial differences in numbering. To over-
come the limited recall for NSM normalization we plan
to incorporate RefSeq transcripts, which are derived
from GenBank and provide current and deprecated
annotations for genes.
We believe the developed corpus will help to facilitate
further development in the normalization of SNPs to
dbSNP identifiers and will assist the community pro-
gress toward a common corpus useful for the systematic
evaluation of grounding tools. The annotated corpus is
available at http://www.scai.fraunhofer.de/snp-normali-
zation-corpus.html.
List of abbreviations and recently used biological
terms
￿ cDNA: Complementary DNA
￿ gDNA: Genomic DNA
￿ IVS: Intervening Sequence
￿ Mutation: Refers to rare variants which often cause
diseases and affect conserved residues in the protein
sequence. Also used to refer to modified residues in a
sequence after the experimental procedure of mutagen-
esis; NSM: Nucleotide Sequence Mutation
Table 8 SNPs without gene association according to
dbSNP
PMID SNP mention dbSNP identifier Entrez Gene Identifier
15823203 –3608T>C rs7379701 9607
16670163 g.-420C–>G rs862513 56729
17363416 c.-9610G>A rs8007267 2643
17604842 -C8347G rs4131347 121278
18059035 G-2548A rs7799039 3952
The last column mentions the associated gene according to the original
article.
Table 9 Mentions of protein sequence mutations which
might also refer to a nucleotide sequence mutation
PMID SNP dbSNP identifier
16336637 A206T rs2235491
16336637 G870A rs603965
17096334 A394T rs2305160
…… …
Table 10 Examples of SNPs where a change of
directionality between textual description and dbSNP
entry can be observed
PMID SNP dbSNP identifier
17582620 IVS3+411C>T rs2486001
18300940 S312N rs2293275
18470941 p.V432L rs1056836
…… …
Table 11 Problematic cases contained in the corpus of
527 SNPs
Occurrence Type
3 Initial amino acid not counted
8 PSM deduced from mature protein
7 dbSNP entry on reverse strand
5 Typing error in rs number
2 Ambiguous dbSNP entries
5 Mutation not associated with the mentioned gene
17 Ambiguous PSM
139 Change of directionality
Thomas et al. BMC Bioinformatics 2011, 12(Suppl 4):S4
http://www.biomedcentral.com/1471-2105/12/S4/S4
Page 15 of 18￿ PSM: Protein Sequence Mutation; SNP: Single
Nucleotide Polymorphisms or SNPs are DNA sequence
variations in which a single nucleotide (A, G, C or T) is
altered. SNPs are also referred as polymorphisms, natural
variants, or common variants because they have a minor
allele frequency in the population of at least 1 %. In con-
trast, rare variants have a minor allele frequency of less
than 1 %. SNP mention: Textual description of a SNP
￿ UTR: Untranslated Region
￿ Variation: Any kind of short range sequence varia-
tion in the nucleotide sequence of the genome
￿ Variation mention: Textual description of a variation
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